Table 4.

Adverse events after vaccination (either first or second dose) in MIVAC I and II

	MIVAC I			MIVAC II
	Hold methotrexate (n=80)	Continue methotrexate (n=78)	p value	Hold methotrexate (n=76)	Continue methotrexate (n=81)	p value
Injection site reactions	15 (19%)	16 (21%)	0·84	13 (17%)	9 (11%)	0·35
Fever	10 (13%)	11 (14%)	0·81	2 (3%)	2 (2%)	>0·99
Headache	10 (13%)	4 (5%)	0·16	3 (4%)	5 (6%)	0·72
Myalgia	13 (16%)	7 (9%)	0·23	8 (11%)	5 (6%)	0·39
Fatigue	5 (6%)	3 (4%)	0·72	1 (1%)	3 (4%)	0·62
Vomiting	1 (1%)	0	>0·99	0	0	..
Abdominal pain	1 (1%)	1 (1%)	>0·99	0	0	..

Data are n (%).